Materials Today Bio · 2021 · 14 citations · 51 references
Life SciencesNeurobiologyNeuroscienceDrug DeliveryNanobiotechnologyNanomaterialsBrain Targeted DeliveryNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNervous TissueBrain RegionsMyelin BiologyMyelin LipidsMyelin ProteinsMyelin Sheath StructureTargeted Co-deliveryTargeted DeliveryTargeted Delivery Systems
Neurodegenerative diseases affect millions of people worldwide and the presence of various physiological barriers limits the accessibility to the brain and reduces the efficacy of various therapies. Moreover, new carriers having targeting properties to specific brain regions and cells are needed in order to improve therapies for the brain disorder treatment. In this study, for the first time, Myelin nanoVesicles (hereafter defined MyVes) from brain-extracted myelin were produced. The MyVes have an average diameter of 100-150 nm, negative zeta potential, spheroidal morphology, and contain lipids and the key proteins of the myelin sheath. Furthermore, they exhibit good cytocompatibility. The MyVes were able to target the white matter and interact mainly with the microglia cells. The preliminary results here presented allow us to suppose the employment of MyVes as potential carrier to target the white matter and microglia in order to counteract white matter microglia-related diseases.
51
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney, Natalia L. Klyachko, Yuling Zhao et al. · Journal of Controlled Release · 2015 · 2K citations · Full text
Acute Inflammatory Response in Spinal Cord Following Impact Injury
Sonia L. Carlson, Mark E. Parrish, Joe E. Springer et al. · Experimental Neurology · 1998 · 497 citations
In vitro models for the blood–brain barrier
Per Garberg, Marguerite Ball, Natalia Borg et al. · Toxicology in Vitro · 2004 · 395 citations
Pharmacy, Neuroscience, Pharmacology +14